Medicare Enrolled

Dr. Irina Mezheritskiy, M.D.

Radiation Oncology · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1350 S HICKORY ST, Melbourne, FL 32901
3214347313
In practice since 2006 (19 years)
NPI: 1063578995 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mezheritskiy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mezheritskiy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mezheritskiy

Dr. Irina Mezheritskiy is a radiation oncology in Melbourne, FL, with 19 years in practice. Based on federal Medicare data, Dr. Mezheritskiy performed 6,780 Medicare services across 3,761 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mezheritskiy received a total of $520 from 4 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mezheritskiy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 27% volume in FL$ $520 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,780
Medicare services
Top 27% in FL for radiation oncology
3,761
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~357 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
MRI contrast dye injection (gadoterate)2,941$0$1
Chest X-ray, 1 view863$7$32
CT scan of head/brain, without contrast337$31$145
Screening mammography309$121$251
3D screening mammography (tomosynthesis)256$51$105
CT scan of abdomen and pelvis with contrast151$68$310
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)117$39$105
Ct scan of abdomen and pelvis without contrast104$65$301
Ultrasound study of one arm or leg veins with compression and maneuvers93$17$83
Ct scan of blood vessels of chest with contrast91$69$322
Ct scan of upper spine without contrast89$36$172
Bone density scan (DEXA)89$10$30
Diagnostic mammography of 1 breast88$85$246
Diagnostic mammography of both breasts87$104$309
Limited ultrasound scan of 1 breast81$65$178
X-ray of abdomen, 1 view69$7$33
Chest X-ray, 2 views55$8$36
CT scan of chest, without contrast54$41$175
Hip X-ray, 2-3 views48$9$39
Complete ultrasound scan of 1 breast47$97$267
Mri scan of brain without contrast46$54$254
Ultrasound study of arm or leg veins with compression and maneuvers42$27$130
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries41$391$1,022
Ct scan of blood vessels of head with contrast40$65$285
Ct scan of blood vessels of neck with contrast40$63$285
Nuclear medicine study from skull base to mid-thigh with ct scan37$1,142$3,015
Ct scan of lower spine without contrast36$37$169
Shoulder X-ray, 2+ views33$8$34
Knee X-ray, 3 views29$7$33
Nuclear medicine study of lung ventilation and circulation29$37$177
Limited ultrasound scan behind abdominal cavity28$22$104
X-ray of pelvis, 1-2 views27$7$31
Computed tomography (ct) of brain blood flow, volume, and timing of flow analysis with contrast25$176$250
X-ray of hand, minimum of 3 views22$6$30
Ct scan of leg without contrast21$38$174
Ct scan of chest with contrast20$43$206
Limited ultrasound scan of abdomen20$23$108
X-ray of wrist, minimum of 3 views19$7$29
Biopsy of breast and placement of locating device using ultrasound, first growth18$388$1,145
Mri scan of brain before and after contrast18$88$396
Mri scan of both breasts18$247$780
Ct scan of face without contrast17$30$165
X-ray of surgical specimen16$12$50
Complete ultrasound scan of abdomen16$31$143
X-ray of lower leg, 2 views15$6$29
Foot X-ray, 3+ views15$7$29
Biopsy of breast and placement of locating device using x-ray with needle, first growth14$389$1,172
X-ray of lower and sacral spine, 2-3 views13$7$40
X-ray of ankle, minimum of 3 views13$6$32
Nuclear medicine study of bone and/or joint whole body13$28$132
Low dose ct scan of chest for lung cancer screening12$133$283
X-ray of abdomen, 2 views12$9$38
3d radiographic procedure12$8$56
Ultrasound of both sides of head and neck blood flow12$31$144
Placement of locating device in breast using ultrasound guidance, first growth11$286$852
Ct scan of middle spine without contrast11$37$170
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$520
Total received (2019-2024)
Avg $87/year across 6 years
Top 32% in FL for radiation oncology
4
Companies
7
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$520 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25
2023
$123
2022
$125
2021
$73
2020
$113
2019
$61

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$248
Janssen Pharmaceuticals, Inc
$134
Karyopharm Therapeutics Inc.
$113
Bard Peripheral Vascular, Inc.
$25
Top 3 companies account for 95.2% of total payments
Associated products mentioned in payments ›
IMFINZI · LYNPARZA · XARELTO · XPOVIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $8 per 100 Medicare services performed
Looking for a radiation oncology in Melbourne?
Compare radiation oncologys in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologys nearby

Geographic Context

Radiation Oncologys within 10 mi
51
Per 100K population
8.2
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mezheritskiy is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mezheritskiy experienced with mri contrast dye injection (gadoterate)?
Based on Medicare claims data, Dr. Mezheritskiy performed 2,941 mri contrast dye injection (gadoterate) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mezheritskiy receive payments from pharmaceutical companies?
Yes. Dr. Mezheritskiy received a total of $520 from 4 companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mezheritskiy's costs compare to other radiation oncologys in Melbourne?
Dr. Mezheritskiy's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mezheritskiy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →